Why Invest in Theralase?

• Proven clinical laser technology (TLC-1000)
• Commercial therapeutic laser business and brand developed over last 18 years
• No debt
• Positive cash flow / double digit growth
• Photo Dynamic Compound (PDC) cancer destruction in animals proven successful
• PDCs destroy Bladder Cancer using cutting edge technology
• Competitive technical advantage (3 known Cellular pathways: iNOS, ATP, Na+ / K+)
• Large addressable US market ($ billions)
• Future technology (Patented biofeedback laser technology and patented PDC cancer destruction)
• Opportunity for growth (revenue, profit)
• IP protection (multiple issued patents)
• Strong Medical and Scientific Advisory Board to offer guidance
• Experienced management team (20+ years)
• Clear vision and execution strategy
• Listed on the TSX Venture exchange V:TLT

For more information, please call 1-866-843-5273 or visit www.theralase.com